Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. read more
Gavin MacBeath Ph.D. ā Founder at Merrimack Pharmaceuticals
Executive Bio
Dr. Gavin MacBeath, Ph.D., has been Chief Scientific Officer at Abpro Corporation since March 2017. Dr. MacBeath is a Co-Founder of Merrimack Pharmaceuticals, Inc. and served as its Senior Director and the Head of Translational Research. At Merrimack, Dr. MacBeath is responsible for leading the MM-121 research team and creating its general strategy for predictive medicine. He continues to direct a research lab at Harvard Medical School in the Department of Systems Biology. Dr. MacBeath was an Assistant Professor in the Department of Chemistry and Chemical Biology at Harvard University. Over the four years, he has pioneered the development of protein microarray technology. Dr. MacBeath was an Associate Professor in the Department of Chemistry and Chemical Biology at Harvard University. He is also interfacing protein microarray technology with high-throughput screening to extend the field of chemical genomics. Dr. MacBeath has over 16 years of experience in academia and the biotechnology industry, with expertise in systems biology, drug discovery, translational research, companion diagnostics and clinical development of early-stage programs. He has an extensive scientific background and expertise in developing new technologies as evidenced by his achievements in both academia and in the clinic. His scientific leadership is be invaluable as advance antibody programs under best-in-class DiversImmuneTM industrial biochemistry platform across large indications including ophthalmology, autoimmunity and immune-oncology. He served as Member of Scientific Advisory Board of Merrimack Pharmaceuticals, Inc. He has been a Member of the Scientific Advisory Board at Aushon BiosyStems, Inc. since September 2010. He is an associate member of the Broad Institute of MIT and Harvard. Dr. MacBeath received his B.Sc.(Hons.) degree in Genetics from the University of Manitoba in 1991 and his Ph.D. in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute in 1997, training with Professor Donald Hilvert.
Executive Team Culture Ratings from Merrimack Pharmaceuticals Employees
TOP
50%
Merrimack Pharmaceuticals' Executive Team scores in the Top 50%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Merrimack PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Merrimack PharmaceuticalsMerrimack Pharmaceuticals' Executive Team at a Glance
Based on 6 ratings, Merrimack Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āC+ā or 69/100.
Merrimack Pharmaceuticals' Executive Team ranks in the Top 50% of other companies in Boston and Top 50% of other companies on Comparably that also have 201-500 Employees.
×